Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics?

Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics?

The pathological accumulation of alpha-synuclein governs the pathogenesis of neurodegenerative disorders, such as Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy, collectively termed alpha-synucleinopathies. Alpha-synuclein can be released in the extracellular space, part...

Full description

Bibliographic Details
Main Authors:	Panagiota Mavroeidi, Maria Vetsi, Dimitra Dionysopoulou, Maria Xilouri
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Biomolecules
Subjects:	alpha-synuclein biomarkers exosomes glia neurons
Online Access:	https://www.mdpi.com/2218-273X/12/7/957

Similar Items

Neurons and Glia Interplay in α-Synucleinopathies
by: Panagiota Mavroeidi, et al.
Published: (2021-05-01)

In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
by: Maria Fouka, et al.
Published: (2020-09-01)

GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds
by: Kathrin Brockmann, et al.
Published: (2020-09-01)

Role of exosomes in the pathogenesis of inflammation in Parkinson’s disease
by: Ke-Lu Li, et al.
Published: (2022-01-01)

Exosomal cell-to-cell transmission of alpha synuclein oligomers
by: Danzer Karin M, et al.
Published: (2012-08-01)

Autophagy in α-Synucleinopathies—An Overstrained System
by: Lisa Fellner, et al.
Published: (2021-11-01)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
by: Inês C. Brás, et al.
Published: (2021-02-01)

Immune responses in the Parkinson's disease brain
by: Fiona Weiss, et al.
Published: (2022-06-01)

Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?
by: Bradley Roberts, et al.
Published: (2022-08-01)

Intrastriatal Administration of Exosome-Associated Pathological Alpha-Synuclein Is Not Sufficient by Itself to Cause Pathology Transmission
by: Mantia Karampetsou, et al.
Published: (2020-04-01)

Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
by: Shuanglong Yi, et al.
Published: (2022-11-01)

Exosomes as mediators of neuron-glia communication in neuroinflammation
by: María Pascual, et al.
Published: (2020-01-01)

Meta-analysis to implement alpha-synuclein in extracellular vesicles as a potential biomarker for parkinson’s disease
by: Víctor H. Juárez-Vaquera, et al.
Published: (2023-10-01)

The Role of Glial Mitochondria in α-Synuclein Toxicity
by: Yu-Mi Jeon, et al.
Published: (2020-11-01)

Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
by: Lydia Alvarez-Erviti, et al.
Published: (2011-06-01)

Sex and Age Differences in a Progressive Synucleinopathy Mouse Model
by: Jérôme Lamontagne-Proulx, et al.
Published: (2023-06-01)

Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson’s Disease
by: Kyu Hwan Shim, et al.
Published: (2021-05-01)

Corrigendum: Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson's Disease
by: Kyu Hwan Shim, et al.
Published: (2021-07-01)

Preclinical Detection of Alpha-Synuclein Seeding Activity in the Colon of a Transgenic Mouse Model of Synucleinopathy by RT-QuIC
by: Jung-Youn Han, et al.
Published: (2021-04-01)

Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
by: Thuy Thi Lai, et al.
Published: (2022-01-01)

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
by: Naomi P. Visanji, et al.
Published: (2019-09-01)

The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
by: Rachel Kelly, et al.
Published: (2021-11-01)

Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson’s Disease
by: Megan F. Duffy, et al.
Published: (2018-09-01)

Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy
by: Suzhen Lin, et al.
Published: (2023-03-01)

Internalization, axonal transport and release of fibrillar forms of alpha-synuclein
by: Gregor Bieri, et al.
Published: (2018-01-01)

Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model
by: Chunni Zhu, et al.
Published: (2021-04-01)

Toward a Disease-Modifying Therapy of Alpha-Synucleinopathies: New Molecules and New Approaches Came into the Limelight
by: Matthew Upcott, et al.
Published: (2021-12-01)

Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies
by: Gábor G. Kovács, et al.
Published: (2004-11-01)

Targeted Extracellular Vesicle Gene Therapy for Modulating Alpha-Synuclein Expression in Gut and Spinal Cord
by: Maria Izco, et al.
Published: (2023-04-01)

SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models
by: Oh‐Chan Kwon, et al.
Published: (2021-04-01)

Automated algorithm development to assess survival of human neurons using longitudinal single-cell tracking: Application to synucleinopathy
by: Jeonghoon Choi, et al.
Published: (2023-04-01)

Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity
by: Marcelina J. Wojewska, et al.
Published: (2023-08-01)

Enteric synucleinopathy: real entity or only a trendy concept?
by: Adrien de Guilhem de Lataillade, et al.
Published: (2020-08-01)

Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson's Disease Mouse Model
by: Thuy Thi Lai, et al.
Published: (2021-10-01)

A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration
by: Alexia Polissidis, et al.
Published: (2022-02-01)

Solubility of α-synuclein species in the L62 mouse model of synucleinopathy
by: Karima Schwab, et al.
Published: (2024-03-01)

α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
by: Simon Oliver Hoppe, et al.
Published: (2021-06-01)

Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?
by: Arati Tripathi, et al.
Published: (2021-12-01)

Editorial: The Protein Alpha-Synuclein: Its Normal Role (in Neurons) and Its Role in Disease
by: Ruth G. Perez
Published: (2020-02-01)

Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease
by: Yong Hui Koh, et al.
Published: (2018-11-01)